The brain regions involved include the hypothalamus, hippocampus, and brainstem, which express GLP-1 receptors
In general, it is considered a multifactorial metabolic disease characterized by several clinical manifestations such as hyperandrogenism, polycystic ovaries aspects on ultrasound and ovulatory dysfunctions which makes it the most common cause of anovulation infertility in women, but also from metabolic problems such as obesity, insulin resistance, hyperinsulinemia and type II diabetes which may enhance cardiovascular complications and other neurological and psychological implication such as anxiety and depression [2, 3]
Without dedicated clinical trials, we're operating in the realm of educated hypothesis
The vast majority of patients move past the acute side-effect phase entirely and enjoy consistent appetite control with no ongoing discomfort
Reconstituted to 2.0 mg/mL, it requires 5 mL
The BALANCE Model is a different GLP-1 program being created to replace the Bridge program
